Complete financial analysis of Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangsu Apon Medical Technology Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Chesapeake Gold Corp. (CKG.V) Income Statement Analysis – Financial Results
- Shaanxi Fenghuo Electronics Co., Ltd. (000561.SZ) Income Statement Analysis – Financial Results
- Best World International Limited (CGN.SI) Income Statement Analysis – Financial Results
- Wiselink Co., Ltd. (8932.TWO) Income Statement Analysis – Financial Results
- FLEETCOR Technologies, Inc. (FLT) Income Statement Analysis – Financial Results
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
About Jiangsu Apon Medical Technology Co., Ltd.
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 422.17M | 323.81M | 461.21M | 443.08M | 379.65M | 298.03M | 246.92M | 198.30M | 153.52M | 120.35M |
| Cost of Revenue | 145.71M | 163.76M | 166.33M | 188.59M | 112.02M | 70.03M | 62.28M | 50.95M | 40.13M | 33.88M |
| Gross Profit | 276.46M | 160.05M | 294.88M | 254.48M | 267.63M | 228.00M | 184.64M | 147.36M | 113.39M | 86.47M |
| Gross Profit Ratio | 65.49% | 49.43% | 63.94% | 57.44% | 70.49% | 76.50% | 74.78% | 74.31% | 73.86% | 71.85% |
| Research & Development | 36.55M | 34.95M | 43.98M | 23.55M | 24.50M | 20.98M | 20.03M | 15.36M | 9.78M | 6.72M |
| General & Administrative | 31.62M | 22.51M | 38.48M | 20.90M | 21.99M | 24.76M | 19.33M | 19.61M | 26.04M | 24.67M |
| Selling & Marketing | 147.71M | 142.60M | 126.33M | 91.44M | 103.46M | 81.57M | 63.18M | 47.88M | 37.74M | 24.31M |
| SG&A | 224.99M | 165.12M | 164.81M | 112.34M | 125.45M | 106.33M | 82.51M | 67.48M | 63.78M | 48.97M |
| Other Expenses | 876.41K | -2.39M | -487.16K | -1.62M | -2.91M | -1.82M | -938.11K | 8.37M | 6.09M | 4.20M |
| Operating Expenses | 262.76M | 231.97M | 235.50M | 146.34M | 171.87M | 141.42M | 115.02M | 100.73M | 85.15M | 50.47M |
| Cost & Expenses | 408.20M | 395.73M | 401.83M | 334.93M | 283.89M | 211.46M | 177.30M | 151.67M | 125.28M | 84.35M |
| Interest Income | 2.31M | 2.08M | 3.61M | 7.24M | 7.36M | 1.01M | 331.83K | 134.63K | 35.60K | 0.00 |
| Interest Expense | 3.07M | 2.47M | 1.13M | 1.48K | 88.18K | 1.10M | 82.59K | 47.79K | 142.22K | 106.77K |
| Depreciation & Amortization | 23.43M | 22.96M | 16.59M | 10.41M | 11.02M | 10.12M | 7.19M | 6.31M | 2.96M | 2.23M |
| EBITDA | 41.91M | -64.34M | 74.80M | 122.66M | 105.50M | 95.75M | 77.35M | 64.03M | 34.70M | 37.02M |
| EBITDA Ratio | 9.93% | -15.83% | 17.07% | 28.13% | 28.53% | 32.65% | 31.83% | 32.65% | 24.56% | 30.76% |
| Operating Income | 13.97M | -88.32M | 55.79M | 113.53M | 120.73M | 85.56M | 70.69M | 49.11M | 27.34M | 34.80M |
| Operating Income Ratio | 3.31% | -27.28% | 12.10% | 25.62% | 31.80% | 28.71% | 28.63% | 24.77% | 17.81% | 28.91% |
| Total Other Income/Expenses | -157.71K | -1.57M | -487.15K | -1.62M | -2.91M | -1.82M | -938.11K | 8.37M | 6.09M | 4.20M |
| Income Before Tax | 13.81M | -90.71M | 55.30M | 111.91M | 117.82M | 83.74M | 69.76M | 57.49M | 33.44M | 39.00M |
| Income Before Tax Ratio | 3.27% | -28.01% | 11.99% | 25.26% | 31.03% | 28.10% | 28.25% | 28.99% | 21.78% | 32.41% |
| Income Tax Expense | 5.36M | -14.16M | 1.98M | 15.04M | 14.99M | 12.65M | 9.56M | 8.18M | 3.74M | 6.83M |
| Net Income | 8.28M | -76.38M | 54.06M | 96.96M | 102.34M | 70.09M | 57.92M | 47.70M | 28.90M | 31.38M |
| Net Income Ratio | 1.96% | -23.59% | 11.72% | 21.88% | 26.96% | 23.52% | 23.46% | 24.06% | 18.82% | 26.08% |
| EPS | 0.07 | -0.61 | 0.43 | 0.77 | 0.81 | 0.74 | 0.62 | 0.51 | 0.23 | 0.75 |
| EPS Diluted | 0.07 | -0.61 | 0.43 | 0.77 | 0.81 | 0.74 | 0.62 | 0.51 | 0.23 | 0.75 |
| Weighted Avg Shares Out | 125.99M | 126.05M | 126.05M | 126.05M | 126.05M | 94.26M | 94.12M | 94.20M | 126.05M | 41.63M |
| Weighted Avg Shares Out (Dil) | 125.99M | 126.06M | 126.05M | 126.05M | 126.05M | 94.26M | 94.12M | 94.20M | 126.05M | 41.63M |
Source: https://incomestatements.info
Category: Stock Reports